hsa-mir-600: Hsa-mir-600 is a microRNA (miRNA) that has been identified in various studies [PMC3726785] [PMC9293659] [PMC3794036] [PMC5635130] [PMC7196262] [PMC2630984] [PMC4951313] [PMC5403669]. It has been associated with lung cancer and other types of cancer, such as breast, colorectal, and ovarian cancer [PMC7196262] [PMC9952540]. Hsa-mir-600 has been found to be upregulated in certain conditions, including high-grade Gleason score and presence of extraprostatic extension in prostate cancer patients, as well as lymphatic invasion in lung cancer patients [PMC7196262]. In silico analysis has predicted that hsa-mir-600 can bind to specific target regions and potentially alter miRNA regulation [PMC5635130]. Hsa-mir-600 has also been identified as a miRNA that can bind to the 3'UTR of certain genes, such as G72, and potentially affect their expression levels [PMC2630984]. Inhibition of hsa-mir-600 has been shown to modulate the expression levels of various target proteins in cell studies, including KI-67 and MEGF10 in SH-SY5Y cells [PMC4951313]. Overall, hsa-mir-600 is a miRNA that has been implicated in various types of cancer and may play a role in regulating gene expression.